These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 7648786)

  • 1. Plasma endothelin levels in NIDDM patients with macroangiopathy.
    Donatelli M; Colletti I; Bucalo ML; Russo V; Verga S
    Diabetes Res; 1994; 25(4):159-64. PubMed ID: 7648786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma endothelin-1 concentrations in non-insulin-dependent diabetes mellitus and nondiabetic patients with chronic arterial obstructive disease of the lower limbs.
    Mangiafico RA; Malatino LS; Santonocito M; Spada RS
    Int Angiol; 1998 Jun; 17(2):97-102. PubMed ID: 9754897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nitrite plasma levels in type 1 and 2 diabetics with and without complications.
    Ferlito S; Gallina M
    Minerva Endocrinol; 1999; 24(3-4):117-21. PubMed ID: 10953727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Significance of increased endothelin level for development of sequelae of diabetes mellitus].
    Haak T; Jungmann E; Hillmann U; Felber A; Usadel KH
    Med Klin (Munich); 1993 May; 88(5):291-6. PubMed ID: 8326915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nitrite plasma levels in type 1 and 2 diabetics with and without complications.
    Ferlito S; Gallina M
    Panminerva Med; 1998 Dec; 40(4):304-8. PubMed ID: 9973826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vascular damage and not hypertension per se influences endothelin-1 plasma levels in patients with non insulin dependent diabetes mellitus.
    Perfetto F; Tarquini R; de Leonardis V; Piluso A; Becucci A; Anselmi B; Curradi C; Tapparini L; Tarquini B
    Recenti Prog Med; 1997; 88(7-8):317-20. PubMed ID: 9270291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The relationship between the plasma levels of endothelin and angiopathy in diabetic patients].
    Zeng ZP; Tang D; Sun ML
    Zhonghua Nei Ke Za Zhi; 1994 Jul; 33(7):467-9. PubMed ID: 7867443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Susceptibility of LDL to lipid peroxidation in non-insulin-dependent diabetes mellitus with or without macroangiopathy].
    Gallou G; Ruelland A; Campion L; Allannic H; Legras B; Cloarec L
    Ann Biol Clin (Paris); 1994; 52(10):695-9. PubMed ID: 7747876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma levels of endothelin, lipid peroxides and prostacyclin in diabetic patients with macroangiopathy.
    Migdalis IN; Kalogeropoulou K; Iliopoulou V; Triantafilou P; Charalabides J; Mortzos G; Cordopatis C
    Diabetes Res Clin Pract; 2001 Nov; 54(2):129-36. PubMed ID: 11640996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical analysis of serum endothelin in type 2 diabetic patients with vascular complications].
    Fang YH; Zhang JP; Zhou SX; Zheng JF; Yu YW; Yan SG; Fan WK; Chen YS
    Di Yi Jun Yi Da Xue Xue Bao; 2005 Aug; 25(8):1007-8, 1011. PubMed ID: 16109562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum lipoprotein (a) concentrations in a population of 819 non-insulin-dependent diabetic patients.
    Durlach V; Gillery P; Bertin E; Taupin JM; Grulet H; Gross A; Leutenegger M
    Diabetes Metab; 1996 Oct; 22(5):319-23. PubMed ID: 8896993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nicotinamide effects oxidative burst activity of neutrophils in patients with poorly controlled type 2 diabetes mellitus.
    Osar Z; Samanci T; Demirel GY; Damci T; Ilkova H
    Exp Diabesity Res; 2004; 5(2):155-62. PubMed ID: 15203886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum visfatin and its relation to insulin resistance and inflammation in type 2 diabetic patients with and without macroangiopathy.
    Alghasham AA; Barakat YA
    Saudi Med J; 2008 Feb; 29(2):185-92. PubMed ID: 18246224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of the body mass index and triglyceride levels in identifying insulin-sensitive and insulin-resistant variants in Japanese non-insulin-dependent diabetic patients.
    Taniguchi A; Fukushima M; Sakai M; Kataoka K; Nagata I; Doi K; Arakawa H; Nagasaka S; Tokuyama K; Nakai Y
    Metabolism; 2000 Aug; 49(8):1001-5. PubMed ID: 10954017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endothelin-1 levels and albuminuria in patients with type 2 diabetes mellitus.
    Zanatta CM; Gerchman F; Burttet L; Nabinger G; Jacques-Silva MC; Canani LH; Gross JL
    Diabetes Res Clin Pract; 2008 May; 80(2):299-304. PubMed ID: 18346810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum leptin levels in female patients with NIDDM.
    Haque Z; Rahman MA
    J Coll Physicians Surg Pak; 2003 Mar; 13(3):130-4. PubMed ID: 12689528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased plasma levels of immunoreactive endothelin and von Willebrand factor in NIDDM patients.
    Morise T; Takeuchi Y; Kawano M; Koni I; Takeda R
    Diabetes Care; 1995 Jan; 18(1):87-9. PubMed ID: 7698054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of non-insulin-dependent diabetes mellitus on plasma endothelin-1 levels in patients with advanced atherosclerosis.
    Perfetto F; Tarquini R; Tapparini L; Tarquini B
    J Diabetes Complications; 1998; 12(4):187-92. PubMed ID: 9647335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endothelin-1 and big endothelin-1 in NIDDM patients with and without microangiopathy.
    Kamoi K; Ishibashi M; Yamaji T
    Diabetes Res Clin Pract; 1994 Jul; 24(3):125-9. PubMed ID: 7988343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma endothelin in NIDDM patients with and without complications.
    Bertello P; Veglio F; Pinna G; Gurioli L; Molino P; Alban S; Chiandussi L
    Diabetes Care; 1994 Jun; 17(6):574-7. PubMed ID: 8082527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.